// App-Quantinova.ai

: Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study

Researchers

Presenter

  • Astrid Yeo

Principal Investigators

  • Karen King

  • Beth Harris

  • Zhengyu Xue

  • Toby Johnson

  • Soumitra Ghosh

Medical Centers

  • GlaxoSmithKline, Stevenage, United Kingdom.

  • PAREXEL International, Raleigh/Durham, United States of America

  • Perelman School of Medicine, Philadelphia, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A